Angiocentric T-cell lymphoma presenting as lethal midline granuloma

International Journal of Dermatology

Volumn 36, Issue 6, 1997, Pages 419-427

  Lee, Peter Y ^b   Freeman, Nancy J ^b   Khorsand, Jila ^b   Weinstock, Martin A ^a  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUCONAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TAZOBACTAM; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDLINE GRANULOMA; PALATE DISEASE; T CELL LYMPHOMA;

EID: 0030841137     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00078.x     Document Type: Article

References (37)

1. Lipford EH, Margolick JB, Longo DL, et al. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post thymic T-cell proliferations. Blood 1988; 72: 1674-1681.
2. McBride P. Photographs of a case of rapid destruction of the nose and face. J Laryngol Rhin Otol 1897; 12: 64-66.
3. Stewart JP. Progressive lethal granulomatous ulceration of nose. J Laryngol Otol 1933; 48: 657-701.
4. Friedman I. The pathology of malignant granuloma of the nose. J Laryngol 1955; 69: 331-341.
5. Eichel BS, Harrison EG Jr, Devine KD, et al. Primary lymphoma of the nose including relationship to lethal midline granuloma. Am J Surg 1966; 112: 597-605.
6. Kassel SH, Echevarria RA, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 1969; 23: 920-935.
7. Fechner RE, Lamppin DW. Midline malignant reticulosis: a clinicopathologic entity. Arch Otolaryngol 1972; 95: 467-476.
8. Ishii Y, Yamanaka N, Ogawa K, et al. Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma". Cancer 1982; 50: 2336-2344.
9. Yamanaka N, Yasuaki H, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985; 56: 768-776.
10. Yamanaka N, Kataura A, Sambe S, et al. Midfacial T-cell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhin Laryngol 1985; 94: 207-211.
11. Ng CS, Chan JKC, Cheng PNM, Szeto SC. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer 1986; 58: 67-71.
12. Weis JW, Winter MW, Phyliky RE, Banks PM. Peripheral T-cell lymphomas: histologic, immunohistologic, and clinical characterization. Mayo Clin Proc 1986; 61: 411-426.
13. Lippman SM, Grogan TM, Spier CM. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59: 936-939.
14. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987; 11: 418-429.
15. Chott A, Rappersberger K, Schlossarek W, Radaszkiewicz T. Peripheral T-cell lymphomas presenting primarily as lethal midline granuloma. Hum Pathol 1988; 19: 1093-1101.
16. Whittaker S, Foroni L, Luzzatto L, et al. Lymphomatoid granulomatosis - evidence of a clonal T-cell origin and an association with lethal midline granuloma. Q J Med 1988; 68: 645-655.
17. Gaulard P, Henni T, Marolleau JP, et al. Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder. Cancer 1988; 62: 705-710.
18. Lang RH, Gerber HA, Schaffner Y, Burki KH. Heterogeneous malignant non-Hodgkin's lymphomas as a causative disorder in lethal midline granuloma. VirchArch A Pathol Anat 1989; 415: 265-273.
19. Ratech H, Burke JS, Blayney DW, et al. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard palate, including cases of lethal midline granuloma. Cancer 1989; 64: 2525-2531.
20. Gold JE, Ghali V, Gold S, et al. Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature. Cancer 1990; 66: 2407-2413.
21. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128-130.
22. Crange C, Cabane J, Dubois A, et al. Centrofacial malignant granulomas. Clinicopathologic study of 40 cases and review of the literature. Medicine 1991; 71: 179-196.
23. Harabuchi Y, Kataura A, Kobayashi K, et al. Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis. Cancer 1992; 70: 835-839.
24. Jaffe ES. The morphologic spectrum of T-cell lymphoma. Am J Surg Pathol 1988; 12: 158-159.
25. Jaffe ES. Post thymic lymphoid neoplasia. In: Jaffe ES, ed. Surgical Pathology of the Lymph Nodes and Related Organs. Philadelphia: WB Saunders, 1985: 218-248.
26. Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease; clinical, pathologic, and immunologic features of 78 cases. Cancer 1990; 65: 971-998.
27. DeRemee RA, Weiland LH, McDonald TJ. Polymorphic reticulosis, lymphomatoid granulomatosis: two diseases or one? Mayo Clin Proc 1978; 53: 634-640.
28. Chan JKC, Ng CS, Ngan KC, et al. Angiocentric T cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides. Am J Surg Pathol 1988; 12: 861-876.
29. Aozasa K, Ohsawa M, Tajima K. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989; 44: 63-66.
30. Aozasa K, Yang WI, Lee YB, et al. Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer 1991; 52: 673-674.
31. Su IJ, Hsieh HC. Clinicopathological spectrum of Epstein-Barr virus-associated T-cell malignancies. Leukemia Lymphoma 1991; 7: 47-53.
32. Su IJ, Tsai TF, Cheng AL, Chen CC. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. J Am Acad Dermatol 1993; 29: 685-692.
33. Maeda H, Aozasa K, Tsujimura T, et al. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses; a clinicopathologic study of forty-two cases with emphasis on prognostic actors. Eur J Surg Oncol 1988; 14: 9-15.
34. Armitage JO. Treatment of non-Hodgkins lymphomas. N Engl J Med 1993; 328: 1023-1030.
35. + phenotype. Cancer 1995; 75: 894.
36. Borisch B, Hennig I, Laeng R, et al. Association of the subtype 2 of the Epstein-Barr with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858-864.
37. Soler J, Bordes R, Ortuno F, et al. Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. Br J Haematol 1994; 86: 659-662.